Records containing: Prostate Cancer
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2025-02-11Clinical Outcomes of Use of Olaparib in Castration Resistant Prostate Cancer: An Observational Study
-
CLINICAL_TRIALS study record update · 2025-02-11The Addictive Diagnostic Value of Apparent Diffusion Coefficients to PI-RADS 3-5 of Biparametric Magnetic Resonance Imaging in the Diagnosis of Prostate Cancer
-
CLINICAL_TRIALS study record update · 2025-02-10177Lu-PSMA as a Systemic Adjuvant Treatment in Patients With High- and Very High-risk Prostate Cancer After Radical Treatment Using Locoregional Teleradiotherapy and Hormone Therapy
-
CLINICAL_TRIALS study record update · 2025-02-10Salvage MR-guided High-Dose-Rate Brachytherapy for Prostate Bed Recurrence After Radiotherapy in the PSMA PET Scan Era
-
CLINICAL_TRIALS study record update · 2025-02-07Local Cytoreductive Treatments for Men With Newly Diagnosed Metastatic Prostate Cancer in Addition to Standard of Care Treatment
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-02-07Combination of Radium-223 and Lutetium-177 PSMA-I&T in Men with Metastatic Castration-Resistant Prostate Cancer
-
CLINICAL_TRIALS study record update · 2025-02-06Dual-Tracer Theranostic PET
-
CLINICAL_TRIALS study record update · 2025-02-06Quantitative Diffusion MRI for Prostate Cancer Detection and Monitoring
-
CLINICAL_TRIALS study record update · 2025-02-06Randomized Phase II Study Evaluating Late Toxicity Following Intensity-Modulated Radiotherapy and Two Image-Guided Strategies With Corresponding Treatment Margins. (RCMIGI)
-
CLINICAL_TRIALS study record update · 2025-02-04Older Men's Decision Making About Active Surveillance for Prostate Cancer - Aim 3: Decision Aid Efficacy Testing
-
CLINICAL_TRIALS study record update · 2025-02-03A Prospective, Multicenter, Post-marketing Surveillance to Assess Safety of Zytiga (Abiraterone Acetate Tablets 250 mg) in Indian Patients With Metastatic, Castration Resistant Prostate Cancer as Per Locally Approved Prescribing Information
-
CLINICAL_TRIALS study record update · 2025-02-03Marathon of Hope Cancer Centres Network Study for Ontario (MOHCCN-O)
-
CLINICAL_TRIALS study record update · 2025-02-03A Multicenter, Two-arm, Prospective, Observational Study to Characterize the Tolerability of Treatment With Enzalutamide or Abiraterone Acetate (With Prednisone) for Metastatic Castration-Resistant Prostate Cancer (mCRPC)
-
CLINICAL_TRIALS study record update · 2025-02-03PRISMA-PET - Primary Staging of Prostate Cancer: A Randomized Controlled Trial Comparing 18F-PSMA-1007 PET/CT to Conventional Imaging
-
CLINICAL_TRIALS study record update · 2025-02-03Randomized Phase II Study of Pharmacologic Manipulation of AGE (Advanced Glycation Endproducts) Levels in Prostate Cancer Patients Receiving Androgen Deprivation Therapy
-
CLINICAL_TRIALS study record update · 2025-01-31Development of Artificial Intelligence-based Multiplex Network for Individualized Risk Stratification of Prostate Cancer
-
CLINICAL_TRIALS study record update · 2025-01-31Improving Evidence-Based Care for Cancer Patients
-
CLINICAL_TRIALS study record update · 2025-01-31PSMA-PET to Guide Prostatectomy: A Randomized Trial
-
CLINICAL_TRIALS study record update · 2025-01-31The Role of Androgen Deprivation Therapy In Cardiovascular Disease - A Longitudinal Prostate Cancer Study (RADICAL PC1) & A RAndomizeD Intervention for Cardiovascular and Lifestyle Risk Factors in Prostate Cancer Patients (RADICAL PC2)
-
CLINICAL_TRIALS study record update · 2025-01-30Multi-cohort Investigational Study to Evaluate the Impact of Pelvic Mp-3TMRI and Whole-body 68Ga-PSMA PET/CT for Diagnosis of Clinically-significant Prostate Cancer and Pre-surgical Staging.
-
CLINICAL_TRIALS study record update · 2025-01-29A Pilot Study for Optimizing Mental Wellbeing and Heart Health for Black Patients With Prostate Cancer
-
CLINICAL_TRIALS study record update · 2025-01-29Phase II Study of PARP Inhibitor Olaparib and IV Ascorbate in Castration Resistant Prostate Cancer
-
CLINICAL_TRIALS study record update · 2025-01-27Randomized, Multicentre, Phase III Study in Patients With Intermediate-risk T1 T2 Prostate Adenocarcinomas, to Verify the Role of Six Months of Total Androgen Blockade for Two Dosage Levels of Prostate Radiation Therapy (70 Gy and 76 Gy) Versus Prostate Radiation Therapy Alone at 76 Gy
-
CLINICAL_TRIALS study record update · 2025-01-27Maximal Androgen Depletion Followed by Randomization of Maximal Androgen Ablation With Molecular Targeted Therapies
-
CLINICAL_TRIALS study record update · 2025-01-27Biobehavioral Effects of Tai Chi Qigong (TCQ) for Male Cancer Survivors With Fatigue (HERO)